contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


nightingale-health-plcs-financial-reporting-and-annual-general-meeting-in-financial-year-2026-2027

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.

Without getting bogged down in individual cents, we are currently very close to ATL (all-time low) levels. I decided to jump on board now, as it feels like the heavy sell-off (vomiting of shares) won’t last much longer, and I consider Cor Group’s (Olli Karhi) recent share purchase of approximately EUR 5 million to be significant. Progress has been slow, but at this price, I’m willing to see what the future holds. At the same time, I’ll be diving deeper into the company to see if it warrants further accumulation (tankkaus).

Does anyone have information on whether there’s a lower price quote than the one I posted (0.797)… AI (Copilot) couldn’t find one… we are already close to ATL (all-time low) levels unless my information is incorrect… it seems to have taken a slight rebound momentarily, but let’s see. Move this to the “share price venting” thread if it’s bothersome, thanks for your attention.

Does anyone know how those OTC figures work? The volume is 666k, but the Trade Data only shows a single 14k trade.                   otcmarkets.com              OTC Markets | Official site of OTCQX, OTCQB, OTCID and Pink Limited Markets

Update from the OTC side, 666k shares. So now a total of about 3.5 million units have changed hands on that marketplace.

Yeah, good point… it would be more interesting to know who exactly is buying, but they probably fall under the “anonymous” category too, for the most part at least… I’m guessing, since it’s been noted here as well, that things are happening over on the U.S. side.

Known or unknown, when a third of the ownership changes hands rapidly, it will have a broader impact. Someone is buying, and likely not just to become a new passive owner.

Satakieli has nearly a quarter of its owners listed as “Unknown”… that’s quite a lot… although I believe about 5.4M of those moved to known owners? “Unknown” is likely the biggest seller in the recent sell-offs… it will be interesting to track how much the number of unknown owners has decreased in the May report.

Nightingale Health

Nightingale Health Plc | Stock Exchange Release | May 27, 2026 at 16:45:00 EESTDuring financial year 1 July 2026 – 30 June 2027, Nightingale Health Plc will release its financial reports as ...

<div class="mfn-header mfn-header-finland"><p>Nightingale Health Plc | Stock Exchange Release | May 27, 2026 at 16:45:00 EEST</p></div><div class="mfn-body"><p>During financial year 1 July 2026 – 30 June 2027, Nightingale Health Plc will release its financial reports as follows:</p><ul><li>Financial Statements Release for 1 July 2025 – 30 June 2026 on Wednesday, 16 September 2026</li><li>Annual Report for financial year 2025–2026 during week 40/2026</li><li>Half-year Financial Report for 1 July – 31 December 2026 on Tuesday, 9 March 2027.</li></ul><p>Nightingale Health’s Annual General Meeting 2026 will be held on Thursday, 5 November 2026. The Board of Directors will convene the meeting at a later date.</p></div><div class="mfn-footer mfn-contacts mfn-45f764cf54eb"><p><strong class="mfn-heading-1">For further information, please contact</strong><br>Teemu Suna, CEO<br><a href="mailto:ir@nightingalehealth.com" rel="noopener">ir@nightingalehealth.com</a></p></div><div class="mfn-footer mfn-about mfn-ae1623782242"><p><strong class="mfn-heading-1">About Nightingale Health</strong><br>Chronic diseases cause around 75% of deaths globally and place a growing burden on healthcare systems. The way to address this is preventive healthcare, but until recently the tools to detect disease risks at population scale have not existed. Nightingale Health has built them. The Nightingale Health Check is a blood-based risk detection test that identifies risks for multiple chronic diseases, including cardiovascular disease, type 2 diabetes, kidney disease, and fatty liver disease, from a single blood sample. It is designed to be applied population-wide, so healthcare systems can identify the people who would benefit most from preventive action before disease develops.</p><p>Nightingale Health's technology is validated in over 900 peer-reviewed scientific publications and is used in many of the world's leading health studies, including the UK Biobank. In Finland, the Nightingale Health Check is in nationwide healthcare use, and over 200,000 people have already received their results. Nightingale Health operates globally with a parent company in Finland and subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom, and has customers in more than 34 countries across healthcare and medical research. The company's Series B shares are listed on the Main Market of Nasdaq Helsinki and on the OTCQX International market. Read more: <a href="https://nightingalehealth.com/" rel="noopener">https://nightingalehealth.com/</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-image"><p><strong class="mfn-heading-1">Image Attachments</strong><br><a href="https://storage.mfn.se/a/nightingale-health/1c743c71-c04a-4c36-aeb6-e48ad88aa153/nightingale-health.jpeg" rel="noopener">Nightingale Health</a></p></div>